GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Beneish M-Score

YSB (HKSE:09885) Beneish M-Score : -5.80 (As of Jun. 23, 2024)


View and export this data going back to 2023. Start your Free Trial

What is YSB Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -5.8 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for YSB's Beneish M-Score or its related term are showing as below:

HKSE:09885' s Beneish M-Score Range Over the Past 10 Years
Min: -5.8   Med: -5.12   Max: -4.43
Current: -5.8

During the past 4 years, the highest Beneish M-Score of YSB was -4.43. The lowest was -5.80. And the median was -5.12.


YSB Beneish M-Score Historical Data

The historical data trend for YSB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB Beneish M-Score Chart

YSB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - -4.43 -5.80

YSB Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial - - -4.43 - -5.80

Competitive Comparison of YSB's Beneish M-Score

For the Pharmaceutical Retailers subindustry, YSB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YSB's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where YSB's Beneish M-Score falls into.



YSB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of YSB for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.6976+0.528 * 0.9798+0.404 * 0.6864+0.892 * 1.1645+0.115 * 0.8677
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8971+4.679 * -0.701807-0.327 * 0.3094
=-5.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$334 Mil.
Revenue was HK$18,564 Mil.
Gross Profit was HK$1,904 Mil.
Total Current Assets was HK$5,319 Mil.
Total Assets was HK$5,701 Mil.
Property, Plant and Equipment(Net PPE) was HK$229 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$147 Mil.
Selling, General, & Admin. Expense(SGA) was HK$1,881 Mil.
Total Current Liabilities was HK$3,540 Mil.
Long-Term Debt & Capital Lease Obligation was HK$98 Mil.
Net Income was HK$-3,507 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$494 Mil.
Total Receivables was HK$412 Mil.
Revenue was HK$15,941 Mil.
Gross Profit was HK$1,602 Mil.
Total Current Assets was HK$4,115 Mil.
Total Assets was HK$4,588 Mil.
Property, Plant and Equipment(Net PPE) was HK$295 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$151 Mil.
Selling, General, & Admin. Expense(SGA) was HK$1,801 Mil.
Total Current Liabilities was HK$9,353 Mil.
Long-Term Debt & Capital Lease Obligation was HK$111 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(334.352 / 18563.917) / (411.598 / 15940.89)
=0.018011 / 0.02582
=0.6976

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1602.17 / 15940.89) / (1904.185 / 18563.917)
=0.100507 / 0.102575
=0.9798

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5319.09 + 229.383) / 5700.604) / (1 - (4115.084 + 294.824) / 4588.29)
=0.026687 / 0.038878
=0.6864

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=18563.917 / 15940.89
=1.1645

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(150.787 / (150.787 + 294.824)) / (146.643 / (146.643 + 229.383))
=0.338383 / 0.389981
=0.8677

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1881.176 / 18563.917) / (1800.621 / 15940.89)
=0.101335 / 0.112956
=0.8971

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((98.006 + 3539.582) / 5700.604) / ((110.968 + 9353.303) / 4588.29)
=0.638106 / 2.062701
=0.3094

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-3507.21 - 0 - 493.515) / 5700.604
=-0.701807

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

YSB has a M-score of -5.80 suggests that the company is unlikely to be a manipulator.


YSB (HKSE:09885) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.
Executives
Chu Mang Yee 2201 Interest of corporation controlled by you
Meta Group Limited 2201 Interest of corporation controlled by you
Sounda Properties Limited 2201 Interest of corporation controlled by you
Shenzhen Songhe International Capital Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. 2101 Beneficial owner
Shanghai Fosun Pharmaceutical (group) Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd. 2201 Interest of corporation controlled by you
Chen Xiaohong 2201 Interest of corporation controlled by you
H Capital V Gp, L.p. 2201 Interest of corporation controlled by you
H Capital V Gp, Ltd. 2201 Interest of corporation controlled by you
Guo Guangchang 2201 Interest of corporation controlled by you
Fosun Holdings Limited 2201 Interest of corporation controlled by you
Fosun International Holdings Ltd. 2201 Interest of corporation controlled by you
Fosun International Limited 2201 Interest of corporation controlled by you
Miyt Holdings Limited 2101 Beneficial owner

YSB (HKSE:09885) Headlines

No Headlines